Related Experiment Video
Updated: Jul 3, 2025
A Melanoma Patient-Derived Xenograft Model
Published on: May 20, 2019
Using Flavonoid Substitution Status to Predict Anticancer Effects in Human Melanoma Cancers: An In Vitro Study
Katarzyna Jakimiuk1, Łukasz Szoka2, Arkadiusz Surażyński2
1Department of Pharmacognosy, Faculty of Pharmacy with the Division of Laboratory Medicine, Medical University of Białystok, ul. Mickiewicza 2a, 15-230 Białystok, Poland.
Abstract:
Skin cancers are a dominant type of cancer that impacts millions per year. Cancer is a heterogeneous disease triggered by the irreversible impairment of cellular homeostasis and function. In this study, we investigated the activity of 37 structurally diverse flavonoids to find potentially active substances using two melanoma cell lines: C32 and A375. First, the cytotoxic potential and DNA biosynthesis inhibition of flavonoids were tested to determine the most active compounds in cancer and normal cells. Second, the molecular mechanism of the anticancer activity of flavonoids was elucidated using Western blot and immunofluorescence analyses. Compounds 1, 6, 15, and 37 reduced the viability of A375 and C32 cell lines via the intrinsic and extrinsic pathways of apoptosis, whereas 16 and 17 acted in a higher degree via the inhibition of DNA biosynthesis. In our experiment, we demonstrated the anticancer activity of compound 15 (5,6-dihydroxyflavone) for the first time. The in vitro studies pointed out the importance of the flavonoid core in hydroxyl groups in the search for potential drugs for amelanotic melanoma.
Insights
Researchers explored 37 flavonoids for skin cancer treatment. Certain flavonoids, like 5,6-dihydroxyflavone, show promise in killing melanoma cells by inducing apoptosis or inhibiting DNA synthesis.
Area of Science:
- Biochemistry
- Pharmacology
- Oncology
Background:
- Skin cancer, particularly melanoma, is a significant global health concern.
- Cancer arises from disrupted cellular homeostasis, necessitating novel therapeutic strategies.
- Flavonoids are plant-derived compounds with diverse biological activities, including potential anticancer effects.
Purpose of the Study:
- To screen 37 structurally diverse flavonoids for anticancer activity against melanoma.
- To identify specific flavonoids that inhibit melanoma cell viability and proliferation.
- To elucidate the molecular mechanisms underlying the observed anticancer effects of promising flavonoid compounds.
Main Methods:
- Cytotoxicity assays were performed on two melanoma cell lines (C32 and A375) and normal cells.
- DNA biosynthesis inhibition was assessed for selected flavonoids.
- Western blot and immunofluorescence analyses were used to investigate apoptosis pathways.
Main Results:
- Compounds 1, 6, 15, and 37 induced apoptosis in melanoma cells (A375 and C32).
- Compounds 16 and 17 primarily inhibited DNA biosynthesis in melanoma cells.
- Compound 15 (5,6-dihydroxyflavone) demonstrated significant anticancer activity, noted for the first time.
- The presence of hydroxyl groups on the flavonoid core is crucial for activity.
Conclusions:
- Flavonoids exhibit potential as therapeutic agents for amelanotic melanoma.
- Specific flavonoids can target melanoma cells through apoptosis induction or DNA synthesis inhibition.
- 5,6-dihydroxyflavone is a novel compound with demonstrated in vitro anticancer efficacy against melanoma.
Related Concept Videos
02:59Cancer Prevention
Some...
02:50Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...